Drug Research
Catalent Signs Development and Manufacturing Agreement with Trizell for Macrophage-based Advanced Cell Therapy
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
Drug Research
Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab
Avid Bioservices, Inc. and Humanigen, Inc. announced that they have entered into a manufacturing services agreement to expand production capacity for lenzilumab™, Humanigen’s therapeutic...
News
US FDA grants breakthrough therapy designation to Novartis STAMP inhibitor asciminib to treat chronic myeloid leukemia
Novartis announced that asciminib, a novel investigational treatment specifically targeting the ABL myristoyl pocket (STAMP), has been granted Breakthrough Therapy designation (BTD) by the...
News
Thermo Fisher Scientific Launches CE-IVD-Marked High Throughput COVID-19 Diagnostic Assay for Use On Its Automated Amplitude Platform
Thermo Fisher Scientific, the world leader in serving science, today launched its CE-IVD-Marked, Applied Biosystems TaqPath COVID–19 HT Kit that is compatible with the...
Press Releases
Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research
Lonza has expanded its renowned human primary cell offerings with the launch of fully customizable, high-quality cryopreserved Leukopaks. The frozen Leukopaks will enable long-distance...
News
India developing 7 more indigenous Covid-19 vaccines
Union health minister Harsh Vardhan has said that the country is developing seven more Covid-19 vaccines to make them available to every citizen of...
News
China approves Sinovac’s coronavirus vaccine
China’s national regulator has approved Sinovac Biotech’s COVID-19 vaccine for use by the general public. This is the second vaccine approved by China’s National...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read